U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06993064) titled 'Effect of Vitamin D on Inflammatory Markers in Type 2 Diabetes Mellitus in Mexico.' on April 29.
Brief Summary: Type 2 Diabetes Mellitus (T2DM) is a very common disease in Mexico, and its long-term complications affect years of healthy life and a high cost in treatmenty. T2DM is a chronic disease associated to inflammation. We aim to establish if Vitamin D may help decrease this inflammation and improve the condition in adults with T2DM. Patients included in the study will have to take 1 pill/day of vitamin D for six months. The investigators will measure weight, height, waist and hip circumference, systolic and dyastolic blood press...